SH3GL1‐activated FTH1 inhibits ferroptosis and confers doxorubicin resistance in diffuse large B‐cell lymphoma
Elevated SH3GL1 expression in DLBCL patients was associated with a negative prognosis. SH3GL1 plays a crucial role in promoting DLBCL cell survival through the regulation of FTH1-mediated ferroptosis and doxorubicin resistance.
Authors
- Wei Xu (ORCID: https://orcid.org/0000-0003-4208-7477)
- Rui Gao (ORCID: https://orcid.org/0000-0002-0845-1370)
- Zi‐Wen Duan
- Yan Wang (ORCID: https://orcid.org/0000-0002-9232-2212)
- Rong Wang (ORCID: https://orcid.org/0000-0002-9947-4307)
- Li Wang (ORCID: https://orcid.org/0000-0001-5232-3846)
- Yue Li (ORCID: https://orcid.org/0000-0003-4547-064X)
- Wei Hua (ORCID: https://orcid.org/0000-0002-2047-9712)
- Jianyong Li (ORCID: https://orcid.org/0000-0002-9931-4055)
- Jinhua Liang
- Hua Yin
- Wei‐Ting Wang (ORCID: https://orcid.org/0000-0002-2064-9523)
- Hao Shen (ORCID: https://orcid.org/0000-0002-8557-8973)
- Jia‐Zhu Wu
- Chunyu Shang (ORCID: https://orcid.org/0009-0001-5637-3629)
Institutions
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Clinical and Translational Medicine
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1002/ctm2.70246
- Citations
- 6
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 8.83
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation